Ethylmorpholine → N-[(3-chloro-2-methylphenyl)methyl]-1,3-dimethyl-2-oxo-4-imidazolidinecarboxamide

To 1,3-dimethyl-2-oxo-4-imidazolidinecarboxylic acid (6.000 ml, 0.600 mmol) (0.1M solution in dichloromethane) was added the N-ethylmorpholine (0.380 ml, 3.00 mmol), 1-hydroxybenzotriazole hydrate (110 mg, 0.720 mmol) and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (138 mg, 0.720 mmol), and the reaction stirred at RT under argon for 10 minutes. [(3-Chloro-2-methylphenyl)methyl]amine (103 mg, 0.660 mmol) was then added and the reaction left to stir at RT under argon overnight. The reaction mixture was diluted with dichloromethane (15 ml) and then the solution was washed with saturated sodium hydrogen carbonate solution (20 ml), water (20 ml), 3N citric acid solution (20 ml), brine (20 ml) and then dried over magnesium sulphate. The solvent was evaporated in vacuo. The residue was purified by mass-directed automated HPLC. Fractions containing product were combined and solvent evaporated in vacuo, co-evaporated with diethyl ether to give the N-[(3-chloro-2-methylphenyl)methyl]-1,3-dimethyl-2-oxo-4-imidazolidinecarboxamide as a white solid (50 mg, 26.8% yield). LC/MS [M+H]+=296, retention time=1.96 minutes

1. waitthe reaction left
2. stirringto stir at RT under argon overnight
3. washthe solution was washed with saturated sodium hydrogen carbonate solution (20 ml), water (20 ml), 3N citric acid solution (20 ml), brine (20 ml)
4. dry with materialdried over magnesium sulphate
5. customThe solvent was evaporated in vacuo
6. customThe residue was purified
7. additionFractions containing product
8. customsolvent evaporated in vacuo, co-evaporated with diethyl ether

ORD-Eintrag

ord-86acfc54e8104f4683a14952c7ae5ba6

Quelldatensatz

uspto-grants-2011_04

DOI

10.6084/m9.figshare.5104873.v1

Patentnummer

US07932282B2